21 results
8-K
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
27 Jul 23
Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition
4:11pm
package he had while serving as President of Maravai’s Biologics Safety Testing segment. Mr. Martin ceased serving as President of Maravai’s Biologics
8-K
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
19 Oct 22
Departure of Directors or Certain Officers
4:05pm
compensation package, as previously disclosed in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission
10-Q
vhoikd6qcf
12 May 21
Quarterly report
4:26pm
424B4
r7vcg6xphz3s7jix8hd
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
w0423xake
25 Mar 21
Draft registration statement
12:00am
10-K
0zfmzua5
22 Mar 21
Annual report
4:22pm
424B4
aqtqms1qslv qikw3e
23 Nov 20
Prospectus supplement with pricing info
4:36pm
S-1
EX-10.15
m1t2d1dswxto53hayl0
29 Oct 20
IPO registration
5:04pm
S-1
EX-10.17
zcxemdt
29 Oct 20
IPO registration
5:04pm
S-1
z5efeindl14gmk
29 Oct 20
IPO registration
5:04pm
DRS/A
r41vipnh e0e
23 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.15
04nvw8f28qcd6o
14 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.17
75l48rn79p2b9nw7q
14 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
z9875qz4hw1l
14 Oct 20
Draft registration statement (amended)
12:00am